TrialThoracic cancer2023

A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.

Yohei Yabuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.